You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
Johnson and Johnson
Harvard Business School
McKesson
Boehringer Ingelheim

Last Updated: February 25, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ETHOSUXIMIDE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Ethosuximide

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00088452 Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study Unknown status National Institute of Neurological Disorders and Stroke (NINDS) Phase 3 2004-07-01 The purpose of this study is to determine the best initial treatment for childhood absence epilepsy.
NCT00088452 Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study Unknown status Children's Hospital Medical Center, Cincinnati Phase 3 2004-07-01 The purpose of this study is to determine the best initial treatment for childhood absence epilepsy.
NCT00689585 Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS) Terminated McGill University Phase 2 2008-09-01 Pain remains the most debilitating symptom for adult patients suffering from complex regional pain syndrome (CRPS). Most CRPS patients gain little to no relief from current painkillers. The purpose of this study is to evaluate the efficacy and safety of ethosuximide in search of much-needed adjunctive therapy to relieve the pain and suffering associated with CRPS.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Ethosuximide

Condition Name

Condition Name for Ethosuximide
Intervention Trials
Epilepsy 2
Seizures 1
Complex Regional Pain Syndromes 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Ethosuximide
Intervention Trials
Epilepsy 4
Syndrome 3
Epilepsy, Absence 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Ethosuximide

Trials by Country

Trials by Country for Ethosuximide
Location Trials
United States 24
France 3
United Kingdom 3
Egypt 2
China 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Ethosuximide
Location Trials
Pennsylvania 2
Virginia 1
Illinois 1
Michigan 1
Missouri 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Ethosuximide

Clinical Trial Phase

Clinical Trial Phase for Ethosuximide
Clinical Trial Phase Trials
Phase 4 2
Phase 3 3
Phase 2 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Ethosuximide
Clinical Trial Phase Trials
Recruiting 4
Not yet recruiting 4
Terminated 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Ethosuximide

Sponsor Name

Sponsor Name for Ethosuximide
Sponsor Trials
University Hospital, Clermont-Ferrand 3
Cambridge University Hospitals NHS Foundation Trust 1
Children's Hospital Medical Center, Cincinnati 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Ethosuximide
Sponsor Trials
Other 27
NIH 1
U.S. Fed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Mallinckrodt
Medtronic
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.